Accelerating Gastrointestinal Recovery

Inclusion criteria: * Females at least 18 years of age * Have an American Society of Anesthesiologists (ASA) Score of I to III * Are consented for primary, interval, or secondary cytoreduction for ovarian, tubal, or peritoneal cancer * Are scheduled to have their nasogastric tube removed before the first postoperative dose of study medication * Are able to understand the study procedures, have agreed to participate in the study program, and have voluntarily provided informed consent Exclusion criteria: * Females younger than 18 years of age * Known non-gynecologic malignancy presenting with similar signs/symptoms as ovarian, tubal, or peritoneal cancer. * Have taken more than 7 consecutive days of therapeutic doses of opioids immediately prior to surgery * Use illicit drugs or abuse alcohol * Have had a prior total colectomy, gastrectomy, gastric bypass, or have a functional colostomy or ileostomy * Have an ongoing history of short bowel syndrome, chronic constipation (≤3 spontaneous bowel movements per week) or chronic diarrhea * Have received radiation therapy to the abdomen or pelvis within 3 months of scheduled surgery * Have chemotherapy or radiation induced bowel dysfunction * Are pregnant (identified by a positive urine or serum pregnancy test) or lactating, or are not postmenopausal (no menses for at least 1 year) and are of childbearing potential and not using an accepted method of birth control (ie, surgical sterilization, intrauterine contraceptive device, oral …